Immediate Impact
4 from Science/Nature 68 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Edward Seijo being referenced
Biospecimen Reporting for Improved Study Quality (BRISQ)
2011
Biospecimen reporting for improved study quality (BRISQ)
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Edward Seijo | 191 | 91 | 139 | 7 | 441 | |
| Claire S. Zhu | 159 | 102 | 151 | 10 | 491 | |
| Helen M. Moore | 156 | 141 | 144 | 5 | 417 | |
| Hege Bøvelstad | 228 | 37 | 84 | 10 | 441 | |
| Yvonne DeSouza | 161 | 168 | 85 | 6 | 400 | |
| Gwynn Ison | 60 | 67 | 97 | 16 | 416 | |
| Carina Strand | 173 | 58 | 174 | 14 | 399 | |
| NM Hylton | 89 | 24 | 214 | 8 | 503 | |
| Ariel B. Bourla | 122 | 19 | 86 | 17 | 387 | |
| Ryan Goosen | 228 | 11 | 153 | 5 | 495 | |
| Daniel D. Von Hoff | 122 | 43 | 45 | 8 | 394 |
All Works
Loading papers...